Search Results - "Meacci, M."

Refine Results
  1. 1

    Usutu virus infections in humans: a retrospective analysis in the municipality of Modena, Italy by Grottola, A., Marcacci, M., Tagliazucchi, S., Gennari, W., Di Gennaro, A., Orsini, M., Monaco, F., Marchegiano, P., Marini, V., Meacci, M., Rumpianesi, F., Lorusso, A., Pecorari, M., Savini, G.

    Published in Clinical microbiology and infection (01-01-2017)
    “…To monitor the spread and to evaluate the role for public health of Usutu virus (USUV) in an endemic area of Italy. The survey was retrospectively conducted by…”
    Get full text
    Journal Article
  2. 2

    Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study by Carra, E., Codeluppi, M., Mussini, C., Meacci, M., Gennari, W., Orlando, G., Bedini, A., Rossi, L., Menozzi, M., Puzzolante, C., Franceschini, E., Rugna, G.

    Published in BioMed research international (01-01-2016)
    “…Background. Visceral leishmaniasis (VL) caused by Leishmania infantum is endemic in the Mediterranean area. In the last decades a northward spread of the…”
    Get full text
    Journal Article
  3. 3

    Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays by Bedini, A, Garlassi, E, Stentarelli, C, Petrella, S, Meacci, M, Meccugni, B, Meschiari, M, Franceschini, E, Cerri, S, Brasacchio, A, Rumpianesi, F, Richeldi, L, Mussini, C

    Published in New microbes and new infections (01-07-2016)
    “…Abstract The optimal treatment for latent tuberculosis infection (LTBI) in subjects exposed to multidrug-resistant (MDR) tuberculosis (TB) remains unclear, and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections by Ardizzoni, A, Capuccini, B, Baschieri, M. C, Orsi, C. F, Rumpianesi, F, Peppoloni, S, Cermelli, C, Meacci, M, Crisanti, A, Steensgaard, P, Blasi, E

    “…The detection of specific serum antibodies is mainly achieved by enzyme-linked immunosorbent assay (ELISA). Here, we describe the setting up of a…”
    Get full text
    Journal Article
  7. 7

    Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer by Minotti, V, Crino′, L, Meacci, M.L, Corgna, E, Darwish, S, Palladino, M.A, Betti, M, Tonato, M

    Published in Lung cancer (Amsterdam, Netherlands) (01-05-1998)
    “…Twenty-three patients with brain metastases from non-small cell lung cancer (NSCLC) (median age 62 years, Karnofsky PS 50-100) were treated with cisplatin (100…”
    Get full text
    Journal Article
  8. 8

    Posttransplant Mycobacterium Tuberculosis Disease Following Liver Transplantation and the Need for Cautious Evaluation of Quantiferon TB GOLD Results in the Transplant Setting: A Case Report by Codeluppi, M., Cocchi, S., Guaraldi, G., Di Benedetto, F., De Ruvo, N., Meacci, M., Meccugni, B., Esposito, R., Gerunda, G.E.

    Published in Transplantation proceedings (01-05-2006)
    “…This report describes a case of pulmonary tuberculosis in a liver transplant patient without a history of previous exposure to Mycobacterium tuberculosis (MTB)…”
    Get full text
    Journal Article
  9. 9

    Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts by Ferrara, G, Losi, M, D'Amico, R, Cagarelli, R, Pezzi, A M, Meacci, M, Meccugni, B, Marchetti Dori, I, Rumpianesi, F, Roversi, P, Casali, L, Fabbri, L M, Richeldi, L

    “…The tuberculin skin test (TST) does not discriminate between recent and remote latent tuberculosis infection (LTBI). This study was carried out to test two…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.) by Crinò, L, Clerici, M, Figoli, F, Carlini, P, Ceci, G, Cortesi, E, Carpi, A, Santini, A, Di Costanzo, F, Boni, C

    Published in Annals of oncology (01-04-1995)
    “…Cisplatin-based chemotherapy is generally considered the most active treatment for advanced non-small-cell lung cancer. The combination of cisplatin and…”
    Get more information
    Journal Article
  14. 14

    Encephalomyeloradiculopathy associated with Epstein‐Barr virus: primary infection or reactivation? by Merelli, E., Bedin, R., Sola, P., Gentilini, M., Pietrosemoli, P., Meacci, M., Portolani, M.

    Published in Acta neurologica Scandinavica (01-12-1997)
    “…Introduction ‐ Encephalomyeloradiculopathy (EMR) is a new syndrome, characterized by extensive involvement of the nervous system at different levels, including…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer by Crinò, L, Latini, P, Meacci, M, Corgna, E, Maranzano, E, Darwish, S, Minotti, V, Santucci, A, Tonato, M

    Published in Annals of oncology (01-12-1993)
    “…High-dose radiation therapy is generally recommended as standard treatment in regionally advanced unresectable non-small-cell lung cancer (NSCLC), but median-…”
    Get more information
    Journal Article
  17. 17

    Growth of human herpesvirus 6 in HEPG2 cells by Cermelli, C., Concari, M., Carubbi, F., Fabio, G., Sabbatini, A.M.T., Pecorari, M., Pietrosemoli, P., Meacci, M., Guicciardi, E., Carulli, N., Portolani, M.

    Published in Virus research (01-12-1996)
    “…HepG2 cells, a well differentiated liver cell line, were shown to be permissive for both human herpesvirus 6 (HHV-6) A and B strains by three independent…”
    Get full text
    Journal Article
  18. 18
  19. 19

    1297PALK AND ROS1-POSITIVE LUNG ADENOCARCINOMA (LA) PATIENT OUTCOMES: A MONO-ISTITUTIONAL EXPERIENCE by Chiari, R., Metro, G., Bennati, C., Iacono, D., Giannarelli, D., Minotti, V., Marcomigni, L., Meacci, M., Crinò, L.

    Published in Annals of oncology (01-09-2014)
    “…Abstract Aim: ALK and ROS1 gene rearrangements are the “oncogenic drivers” of two subsets of LA that have been shown to be sensitive to the ALK inhibitor…”
    Get full text
    Journal Article
  20. 20